Nuformix (LON:NFX) Shares Down 18.5% – Here’s What Happened

Nuformix plc (LON:NFX)’s share price traded down 18.5% during trading on Monday . The company traded as low as GBX 0.05 ($0.00) and last traded at GBX 0.05 ($0.00). 45,228,297 shares traded hands during mid-day trading, an increase of 84% from the average session volume of 24,550,277 shares. The stock had previously closed at GBX 0.07 ($0.00).

Nuformix Stock Performance

The business’s fifty day moving average price is GBX 0.05 and its 200-day moving average price is GBX 0.11. The stock has a market cap of £434,234.30, a PE ratio of -1.63 and a beta of 1.22. The company has a debt-to-equity ratio of 1.17, a quick ratio of 3.35 and a current ratio of 1.12.

Nuformix Company Profile

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.